-
Signature
-
/s/ Aik Na Tan
-
Issuer symbol
-
WVE
-
Transactions as of
-
08 Dec 2025
-
Net transactions value
-
-$1,244,888
-
Form type
-
4
-
Filing time
-
10 Dec 2025, 21:45:11 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Tan Aik Na |
Director |
C/O WAVE LIFE SCIENCES LTD.,, 733 CONCORD AVE., CAMBRIDGE |
/s/ Aik Na Tan |
10 Dec 2025 |
0001821285 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
WVE |
Ordinary Shares |
Sale |
$95,548 |
-7,494 |
-19% |
$12.75 |
32,894 |
08 Dec 2025 |
Direct |
F1 |
| transaction |
WVE |
Ordinary Shares |
Sale |
$112,410 |
-7,494 |
-23% |
$15.00 |
25,400 |
08 Dec 2025 |
Direct |
F1 |
| transaction |
WVE |
Ordinary Shares |
Options Exercise |
$173,075 |
+32,230 |
+127% |
$5.37 |
57,630 |
08 Dec 2025 |
Direct |
F1 |
| transaction |
WVE |
Ordinary Shares |
Sale |
$191,250 |
-15,000 |
-26% |
$12.75 |
42,630 |
08 Dec 2025 |
Direct |
F1 |
| transaction |
WVE |
Ordinary Shares |
Sale |
$258,450 |
-17,230 |
-40% |
$15.00 |
25,400 |
08 Dec 2025 |
Direct |
F1 |
| transaction |
WVE |
Ordinary Shares |
Options Exercise |
$206,325 |
+45,000 |
+177% |
$4.58 |
70,400 |
08 Dec 2025 |
Direct |
F1 |
| transaction |
WVE |
Ordinary Shares |
Sale |
$255,000 |
-20,000 |
-28% |
$12.75 |
50,400 |
08 Dec 2025 |
Direct |
F1 |
| transaction |
WVE |
Ordinary Shares |
Sale |
$375,000 |
-25,000 |
-50% |
$15.00 |
25,400 |
08 Dec 2025 |
Direct |
F1 |
| transaction |
WVE |
Ordinary Shares |
Options Exercise |
$73,500 |
+21,000 |
+83% |
$3.50 |
46,400 |
08 Dec 2025 |
Direct |
F1 |
| transaction |
WVE |
Ordinary Shares |
Sale |
$267,750 |
-21,000 |
-45% |
$12.75 |
25,400 |
08 Dec 2025 |
Direct |
F1 |
| transaction |
WVE |
Ordinary Shares |
Options Exercise |
$125,370 |
+21,000 |
+83% |
$5.97 |
46,400 |
08 Dec 2025 |
Direct |
F1 |
| transaction |
WVE |
Ordinary Shares |
Sale |
$267,750 |
-21,000 |
-45% |
$12.75 |
25,400 |
08 Dec 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
WVE |
Share Option (right to buy) |
Options Exercise |
$0 |
-32,230 |
-100% |
$0.000000 |
0 |
08 Dec 2025 |
Ordinary Shares |
32,230 |
$5.37 |
Direct |
F1, F2 |
| transaction |
WVE |
Share Option (right to buy) |
Options Exercise |
$0 |
-45,000 |
-100% |
$0.000000 |
0 |
08 Dec 2025 |
Ordinary Shares |
45,000 |
$4.58 |
Direct |
F1, F2 |
| transaction |
WVE |
Share Option (right to buy) |
Options Exercise |
$0 |
-21,000 |
-100% |
$0.000000 |
0 |
08 Dec 2025 |
Ordinary Shares |
21,000 |
$3.50 |
Direct |
F1, F2 |
| transaction |
WVE |
Share Option (right to buy) |
Options Exercise |
$0 |
-21,000 |
-100% |
$0.000000 |
0 |
08 Dec 2025 |
Ordinary Shares |
21,000 |
$5.97 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: